GlobeImmune
Edit Page
Report
Scan day: 12 February 2014 UTC
13
Virus safety - good
Description: Tharapies against hepatitis C, EGFR, the Gag protein of the HIV virus and oncogene-related mutations in human cancer. Includes technology overview, progress of clinical trials, and profile of company in Aurora Colorado.
GlobeImmune | Targeted Molecular Therapy is developing Tarmogen product candidates to treat cancer and infectious diseases. Targeted Molecular Immunotherapy Tarmogens activate the immune system by stimulating cellular immunity, known as T cell immunity, in contrast to traditional vaccines, which predominately stimulate antibody production. Tarmogens target the molecular profile that distinguishes a diseased cell from a normal cell, and are designed to target specific antigens that play a role in oncology indications and infectious diseases.
Size: 546 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | GlobeImmune | Targeted Molecular Therapy |
| Keywords: | |
| Description: | |
| IP-address: | 216.92.212.46 |
WHOIS Info
| NS | Name Server: DNS066.A.REGISTER.COM Name Server: DNS204.C.REGISTER.COM Name Server: DNS243.B.REGISTER.COM Name Server: DNS249.D.REGISTER.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 09-nov-2000 Expiration Date: 09-nov-2016 |